Blade Air Mobility, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
Reginald Love, a Director of Blade Air Mobility, Inc., sold 5,091 shares of common stock on August 10, 2026 for $5.75 per share.
William L. Cook Iii, a Director of Blade Air Mobility, Inc., received 44,438 shares of common stock on July 30, 2026.
Reginald Love, a Director of Blade Air Mobility, Inc., received 37,675 shares of common stock on July 30, 2026.
Edward M Philip, a Director of Blade Air Mobility, Inc., received 30,913 shares of common stock on July 30, 2026.
Robert S Wiesenthal, a Director of Blade Air Mobility, Inc., received 50,234 shares of common stock on July 30, 2026.
Andrew Lauck, a Director of Blade Air Mobility, Inc., received 35,260 shares of common stock on July 30, 2026.
Scott M Wunsch, CEO, Logistics of Blade Air Mobility, Inc., reported multiple transactions in common stock on July 30, 2026.
William A. Heyburn, Co-CEO and CFO and a Director of Blade Air Mobility, Inc., reported multiple transactions in common stock on July 30, 2026.
Melissa M. Tomkiel, Co-CEO and General Counsel and a Director of Blade Air Mobility, Inc., reported multiple transactions in common stock on July 30, 2026.
William A. Heyburn amends prior Form 4 filing to correct transaction code for tax withholding related to restricted stock unit vesting.
Amir Cohen amends prior Form 4 filing to correct transaction code for tax withholding related to restricted stock unit vesting.
Melissa M. Tomkiel amends prior Form 4 filing to correct transaction code for shares withheld for tax obligations.
Scott M. Wunsch, CEO of Strata Critical Medical, Inc., filed an amendment to a prior Form 4 to correct a transaction code related to shares withheld for tax obligations.
William A. Heyburn, Co-CEO and CFO of Strata Critical Medical, Inc., reported a transaction involving the sale of 31,671 shares of Class A common stock.
Amir Cohen, Chief Accounting Officer of Strata Critical Medical, Inc., reported a transaction involving the withholding of shares for tax obligations.
Melissa M. Tomkiel, Co-CEO and General Counsel of Strata Critical Medical, Inc., reported a transaction involving the sale of 29,730 shares of Class A common stock.
Amir Cohen, Chief Accounting Officer of Strata Critical Medical, Inc., reported transactions involving Class A common stock, executed under a Rule 10b5-1 trading plan.
Reporting person Velibor Krstic disclosed the expiration of 1,577,500 warrants to purchase Class A Common Stock.
CEO Scott M. Wunsch acquired 57,172 shares of Strata Critical Medical upon performance criteria satisfaction and withheld 13,922 shares for taxes.
Chief Accounting Officer Amir Cohen acquired and disposed of shares of Strata Critical Medical, Inc. following the vesting of performance-based restricted stock units.
Co-CEO and General Counsel Melissa M. Tomkiel acquired 630,264 shares following performance criteria satisfaction and withheld 321,750 shares for tax obligations.
Co-CEO and CFO William A. Heyburn acquired 545,625 shares upon performance criteria satisfaction and withheld 301,731 shares for taxes.
Strata Critical Medical's Chief Accounting Officer, Amir Cohen, filed an amended Form 4 to correct an oversight in previously reported stock ownership.
Strata Critical Medical's CEO, Scott M. Wunsch, was granted 18,067 Restricted Stock Units as part of his quarterly commission program.
Strata Critical Medical, Inc. has granted its Chief Accounting Officer, Amir Cohen, 64,191 Restricted Stock Units with a vesting schedule extending to March 2030.
Scott M. Wunsch, CEO of Trinity Air Medical and an officer of Strata Critical Medical, Inc., was granted 51,353 Restricted Stock Units (RSUs) on February 24, 2026.
Strata Critical Medical's Co-CEO and General Counsel, Melissa M. Tomkiel, exercised stock options to acquire 276,960 shares of Class A common stock at $0.18 per share.
Strata Critical Medical's Co-CEO and General Counsel, Melissa M. Tomkiel, disposed of 34,018 shares of Class A common stock to cover tax obligations related to restricted stock unit vesting.
William A. Heyburn, Co-CEO and CFO of Strata Critical Medical, Inc., reported the disposition of 35,348 shares of Class A common stock to satisfy tax withholding obligations.
Scott M. Wunsch, an officer of Strata Critical Medical, reported a disposition of 21,643 shares of Class A common stock on December 10, 2025, to satisfy tax withholding obligations.